Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

Overview

Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: November 2009

Detailed Description

Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Interventions

  • Other: OPSAT-Q
    • A linguistically validated Korean version of OPSAT-Q

Arms, Groups and Cohorts

  • Bisphosphonates
    • Korean postmenopausal osteoporosis patients with bisphosphonate treatment

Clinical Trial Outcome Measures

Primary Measures

  • Mean of composite satisfaction score (CSS) of OPSAT-QTM
    • Time Frame: 0day

Secondary Measures

  • Mean of subscale satisfaction scores of OPSAT-QTM
    • Time Frame: oday

Participating in This Clinical Trial

Inclusion Criteria

  • Who have been diagnosed with postmenopausal osteoporosis by physician Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire Who provide informed consent for study participation

Exclusion Criteria

  • Do not understand the contents of the questionnaire

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • GlaxoSmithKline
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • GSK Clinical Trials, Study Director, GlaxoSmithKline

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.